Paulette Legarraga
Overview
Explore the profile of Paulette Legarraga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Porte L, Cruz R, Perez I, Varela C, Diaz C, Garcia P, et al.
PLoS One
. 2024 Dec;
19(12):e0315690.
PMID: 39715188
Filamentous fungi are an emergent cause of severe infections in immunocompromised patients. Timely and accurate identification is crucial to initiate appropriate therapy. Traditional identification methods are time-consuming, labor-intensive, and operator-dependent....
2.
Riquelme M, Martinez R, Brito B, Garcia P, Legarraga P, Wozniak A
Infect Drug Resist
. 2023 Oct;
16:6451-6462.
PMID: 37789836
Purpose: Colistin resistance mechanisms involving mutations in chromosomal genes associated with LPS modification are not completely understood. Mutations in genes coding for the MgrB regulator frequently account for colistin resistance...
3.
Porte L, Perez C, Barbe M, Varela C, Vollrath V, Legarraga P, et al.
Pathogens
. 2023 Mar;
12(3).
PMID: 36986425
spp. is an emerging cause of infectious diarrhea worldwide. In South American countries such as Chile, its prevalence is underestimated due to inadequate detection methods. Gastrointestinal multiplex PCR panels (GMP)...
4.
Iruretagoyena M, Vial M, Spencer-Sandino M, Gaete P, Peters A, Delgado I, et al.
BMC Infect Dis
. 2021 May;
21(1):478.
PMID: 34039287
Background: Healthcare workers (HCWs) are at high risk of exposure to SARS-CoV-2. Cross-sectional studies have provided variable rates of seroprevalence in HCWs. Longitudinal assessments of the serological response to Covid-19...
5.
Weitzel T, Perez C, Tapia D, Legarraga P, Porte L
Lancet Infect Dis
. 2021 May;
21(8):1067-1068.
PMID: 33961799
No abstract available.
6.
Valenzuela P, Legarraga P, Rabagliati R
Rev Chilena Infectol
. 2021 Mar;
36(6):732-741.
PMID: 33660752
Background: Invasive fungal disease (IFD) due to filamentous fungi is increasingly common. Aim: To study the epidemiology of EFI in hospitalized adults in our center. Methods: Retrospective study of adult...
7.
Porte L, Legarraga P, Iruretagoyena M, Vollrath V, Pizarro G, Munita J, et al.
PeerJ
. 2021 Feb;
9:e10801.
PMID: 33552746
Background: Real-Time Reverse-Transcription Polymerase Chain Reaction (RT-PCR) is currently the only recommended diagnostic method for SARS-CoV-2. However, rapid immunoassays for SARS-CoV-2 antigen could significantly reduce the COVID-19 burden currently weighing...
8.
Weitzel T, Legarraga P, Iruretagoyena M, Pizarro G, Vollrath V, Araos R, et al.
Travel Med Infect Dis
. 2020 Dec;
39:101942.
PMID: 33278609
No abstract available.
9.
Gutierrez C, Cespedes A, Legarraga P, Morales P, Chanqueo L
Rev Chilena Infectol
. 2020 Aug;
37(3):322-326.
PMID: 32853327
Nocardiosis is a localized or systemic infection that mainly affects immunocompromised patients, with pulmonary localization being the most frequent site. The transmission comes mainly from the inhalation of spores or...
10.
Contreras S, Rodriguez D, Vera F, Balcells M, Celis L, Legarraga P, et al.
Rev Chilena Infectol
. 2020 Aug;
37(3):252-256.
PMID: 32853316
Background: Mycobacterial diseases are very important both clinically and epidemiologically. Mycobacterium tuberculosis complex (MTBc) infections confer higher morbidity and mortality rate than non-tuberculous mycobacteria (NTM) infections. Traditional species identification techniques...